MedPath

Vitamins also healthy after therapeutical radiation? Investigation after the effects of l-ascorbid acid and d-a-tocopherol

Phase 3
Completed
Conditions
Erytheem
Roodheid
10014982
Registration Number
NL-OMON34247
Lead Sponsor
Medisch Spectrum Twente
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
30
Inclusion Criteria

1.Woman diagnosed with breastcancer which have undergone breast saving therapie
2.Radiation according to the new method from 21 treatments.
3.WHO-performace status 0-2
4.Skintyp according to Fitzgerald 1-4
5.Gave their permission

Exclusion Criteria

1.Patientgroup shouldn't be treated or being treated with chemotherapy
2.No radiotherpy in the past
3.No hypertrofia / keloidal scarring
4.No metastases
5.No diabetes mellitus type 1&2
6.No illness which can influence the skinrecovery
7.No medication which couse hypersensibility from the skin
8.No hypersensitivity for one of the ingredients

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Group sample sizes of 15 in both groups to achieve 93% power to detect a<br /><br>difference of 10,0 between the null hypothesis that both group means are 45,0<br /><br>and the alternative hypothesis that the mean of group 2 is 35,0 with estimated<br /><br>group standard deviations of 8,0 and 8,0 and with a significance level (alpha)<br /><br>of 0,05 using a two-sided two-sample t-test.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>nvt</p><br>
© Copyright 2025. All Rights Reserved by MedPath